P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970940.25005.87 |
| _version_ | 1797280829683007488 |
|---|---|
| author | Ailin Zhao Tao Yang Linyu Yang Mengshi Hu Xin Wang Jinjin Wang Meng LI LI Wang Jinbing Zhu Lijuan Chen Ting Niu |
| author_facet | Ailin Zhao Tao Yang Linyu Yang Mengshi Hu Xin Wang Jinjin Wang Meng LI LI Wang Jinbing Zhu Lijuan Chen Ting Niu |
| author_sort | Ailin Zhao |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:45:54Z |
| format | Article |
| id | doaj.art-0bdcdb5046b047438eb9d887a307fc2c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:45:54Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-0bdcdb5046b047438eb9d887a307fc2c2024-03-03T06:25:15ZengWileyHemaSphere2572-92412023-08-017e250058710.1097/01.HS9.0000970940.25005.87202308003-00909P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATIONAilin Zhao0Tao Yang1Linyu Yang2Mengshi Hu3Xin Wang4Jinjin Wang5Meng LI6LI Wang7Jinbing Zhu8Lijuan Chen9Ting Niu101 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, Chinahttp://journals.lww.com/10.1097/01.HS9.0000970940.25005.87 |
| spellingShingle | Ailin Zhao Tao Yang Linyu Yang Mengshi Hu Xin Wang Jinjin Wang Meng LI LI Wang Jinbing Zhu Lijuan Chen Ting Niu P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION HemaSphere |
| title | P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION |
| title_full | P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION |
| title_fullStr | P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION |
| title_full_unstemmed | P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION |
| title_short | P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION |
| title_sort | p1009 sklb054 a novel jak2 inhibitor potently treats myeloproliferative neoplasm with jak2v617f mutation |
| url | http://journals.lww.com/10.1097/01.HS9.0000970940.25005.87 |
| work_keys_str_mv | AT ailinzhao p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT taoyang p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT linyuyang p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT mengshihu p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT xinwang p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT jinjinwang p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT mengli p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT liwang p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT jinbingzhu p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT lijuanchen p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation AT tingniu p1009sklb054anoveljak2inhibitorpotentlytreatsmyeloproliferativeneoplasmwithjak2v617fmutation |